Reply
- PMID: 28376318
- DOI: 10.1053/j.gastro.2017.03.044
Reply
Comment on
-
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27. Gastroenterology. 2016. PMID: 27575820 Free PMC article. Clinical Trial.
-
Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?Gastroenterology. 2017 May;152(6):1624-1625. doi: 10.1053/j.gastro.2017.01.061. Epub 2017 Mar 31. Gastroenterology. 2017. PMID: 28371622 No abstract available.
-
Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.Gastroenterology. 2017 May;152(6):1626-1627. doi: 10.1053/j.gastro.2016.09.070. Epub 2017 Mar 31. Gastroenterology. 2017. PMID: 28371623 No abstract available.
-
RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.Gastroenterology. 2017 May;152(6):1625-1626. doi: 10.1053/j.gastro.2016.09.069. Epub 2017 Apr 1. Gastroenterology. 2017. PMID: 28376319 No abstract available.
-
Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?Gastroenterology. 2017 May;152(6):1627-1628. doi: 10.1053/j.gastro.2016.10.048. Epub 2017 Apr 4. Gastroenterology. 2017. PMID: 28384449 No abstract available.
-
Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization.Gastroenterology. 2017 May;152(6):1623-1624. doi: 10.1053/j.gastro.2017.01.062. Epub 2017 Apr 3. Gastroenterology. 2017. PMID: 28384457 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources